Tuesday, 06 December 2022

 

 

LATEST NEWS International volunteers Day celebrated in Srinagar My Town My Pride : Visiting officers inspect developmental works at MC Handwara, MC Langate 60th Annual Raising Day of Civil Defense & Home Guards celebrated at Srinagar Director Agriculture Kashmir Chowdhary Mohammad Iqbal chairs meeting of Organic/ Bio fertilizer companies Habitual Timber Smugglers to be booked under PSA : Sachin Kumar Vaishya Two day ‘My Town My Pride’ 2.0 concludes at Hajin My Town My pride 2.0 concludes at Shopian My Town My Pride : DC Shopian Sachin Kumar Vaishya chairs joint meeting of ULB Members, Officers Div Com Kashmir inaugurates CBC’s 5-day Multimedia Exhibition on Amrit Mahotsav at Anantnag Welfare of forest workers top priority with State Government : Lal Chand Kataruchak Step closer to resolve Fazilka bus stand issue: Laljit Singh Bhullar instructs to initiate process of shifting bus stand to transport department Harmony is the strength of India's culture : Rajendra Vishwanath Arlekar Dr. Ambedkar paid tribute on the occasion of Mahaparinirvan Divas in Punjab Vidhan Sabha Punjab Government released Rs. 267 lakh for update of M.R. Homes for patients suffering from psychological problems: Dr. Baljit Kaur North Zone’s Pre-Republic Day NSS Parade training Camp concluded at Lovely Professional University Gippy Grewal & Ravneet Grewal Paints The City Red With Their Dance Performance On ‘Nawa Nawa Pyaar' Jos Buttler, Adil Rashid, Shaheen Shah Afridi among nominees for ICC Player of the Month Award for November India will need 1 lakh drone pilots by 2023 : Anurag Singh Thakur Badshah ditches bling in 'Kya Say' music video featuring Sukriti, Prakriti Kantara Starrer Rishab Shetty Finally Revealed The Release Date OF Hindi Version On OTT Kyaa Baat Haii 2.0: Vicky Kaushal & Kiara Advani Featured In Remake Of Harrdy Sandhu’s Song

 

Serum Institute of India seeks emergency use nod for Covishield

Web Admin

Web Admin

5 Dariya News

New Delhi , 07 Dec 2020

Serum Institute of India (SII) has applied for emergency use authorization of the first Made in India Covid-19 vaccine, Covishield."As promised, before the end of 2020, @SerumInstIndia has applied for emergency use authorisation for the first made-in-India vaccine, COVISHIELD. This will save countless lives, and I thank the Government of India and Sri @narendramodiji for their invaluable support," Adar Poonawalla, CEO, SII said in a tweet.Covishield is a vaccine developed by AstraZeneca and Oxford and will be manufactured by SII. Earlier, Pfizer had become the first company to apply for EUA in India and sought permission to import the vaccines here. The UK and US are readying for vaccination programmes with the Pfizer vaccine.In November end, Serum Institute of India (SII) had announced it will seek emergency use authorization for the AstraZeneca Covid 19 vaccine in about two weeks.Poonawalla had said SII is in the process of submitting the data for the clinical trials to the DCGI and will seek emergency use authorization.He said there will be no delays in the AstraZeneca vaccine rollout as the trials are more than enough for establishing efficacy and it will not affect emergency use authorization in Europe and certainly not in India. 

There was a recent error in dosage during trials which AstraZeneca is trying to correct, as per reports."What we might have to do is trials for under 18 candidates. That is way all vaccines go. You first have to establish safety for adults and then go for studies on the impact on children," he added.On the other vaccine, Novavax, where SII has a tie up, Poonawalla said it is two months behind Astrazeneca and the same process will be followed in terms of trials and approvals.The third one, Codagenics is way behind and will take at least a year to get into licence stage. It is only starting stage 1 trials in the UK in December so that will take a year, Poonawalla said.He said both these vaccines can be stored at temperatures of 2 to 8 degrees Celsius for which India has a lot of capacity. He said that for vaccines which much lower temperatures India's capacity for storage is negligible.SII is currently producing 50-60 million (five to six crore) doses a month which by January-February will be scaled up to 100 million (10 crore) doses a month.

 

Tags: Coronavirus , COVID 19 , Novel Coronavirus , India Fights Corona , Fight Against Corona , Corona Virus Updates , Coronavirus Epidemic , Coronavirus Pandemic , Corona virus threat , Corona Outbreak , COVAXIN , COVISHIELD , Covid-19 Vaccine , Covid-19 Vaccine in India , Serum Institute of India , SII , Adar Poonawalla

 

 

related news

 

 

 

Photo Gallery

 

 

Video Gallery

 

 

5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2022 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD